319 related articles for article (PubMed ID: 28473139)
1. Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation.
Chang JD; Manning WJ; Ebrille E; Zimetbaum PJ
J Am Coll Cardiol; 2017 May; 69(18):2331-2341. PubMed ID: 28473139
[TBL] [Abstract][Full Text] [Related]
2. Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads.
Trankle CR; Gertz ZM; Koneru JN; Kasirajan V; Nicolato P; Bhardwaj HL; Ellenbogen KA; Kalahasty G
Pacing Clin Electrophysiol; 2018 Jul; 41(7):845-853. PubMed ID: 29757467
[TBL] [Abstract][Full Text] [Related]
3. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
[TBL] [Abstract][Full Text] [Related]
4. Cardiac electronic implantable devices after tricuspid valve surgery.
Martins RP; Galand V; Leclercq C; Daubert JC
Heart Rhythm; 2018 Jul; 15(7):1081-1088. PubMed ID: 29325973
[TBL] [Abstract][Full Text] [Related]
5. Lead dependent tricuspid dysfunction: Analysis of the mechanism and management in patients referred for transvenous lead extraction.
Polewczyk A; Kutarski A; Tomaszewski A; Brzozowski W; Czajkowski M; Polewczyk M; Janion M
Cardiol J; 2013; 20(4):402-10. PubMed ID: 23913459
[TBL] [Abstract][Full Text] [Related]
6. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM
JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508
[TBL] [Abstract][Full Text] [Related]
7. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation.
Park SJ; Gentry JL; Varma N; Wazni O; Tarakji KG; Mehta A; Mick S; Grimm R; Wilkoff BL
JACC Clin Electrophysiol; 2018 Nov; 4(11):1421-1428. PubMed ID: 30466846
[TBL] [Abstract][Full Text] [Related]
8. Perforated tricuspid valve leaflet resulting from defibrillator leads: a review of the literature.
Wilner BR; Coffey JO; Mitrani R; Carrillo RG
J Card Surg; 2014 Jul; 29(4):470-2. PubMed ID: 24803079
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation.
Addetia K; Harb SC; Hahn RT; Kapadia S; Lang RM
JACC Cardiovasc Imaging; 2019 Apr; 12(4):622-636. PubMed ID: 30947905
[TBL] [Abstract][Full Text] [Related]
10. Severe tricuspid valve regurgitation due to perforation by permanent pacemaker lead.
Wen-Zong L; Liang M
J Card Surg; 2011 Sep; 26(5):555-6. PubMed ID: 21810118
[TBL] [Abstract][Full Text] [Related]
11. Tricuspid Regurgitation Related to Cardiac Implantable Electronic Devices: An Integrative Review.
Gelves-Meza J; Lang RM; Valderrama-Achury MD; Zamorano JL; Vargas-Acevedo C; Medina HM; Salazar G
J Am Soc Echocardiogr; 2022 Nov; 35(11):1107-1122. PubMed ID: 35964911
[TBL] [Abstract][Full Text] [Related]
12. Permanent cardiac pacing and its influence on tricuspid valve function.
Krupa W; Kozłowski D; Derejko P; Swiatecka G
Folia Morphol (Warsz); 2001 Nov; 60(4):249-57. PubMed ID: 11770335
[TBL] [Abstract][Full Text] [Related]
13. Alternative technique for implanting an epicardial cardioverter defibrillation patch during a tricuspid valve replacement for arrhythmogenic right ventricular cardiomyopathy.
Yoda M; Tanabe H; Kishi M; Suma H
Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):628-30. PubMed ID: 21220415
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
[TBL] [Abstract][Full Text] [Related]
15. Severe Tricuspid Valve Injury During Right Ventricular Lead Extraction.
Hai T; Lerner AB; Khamooshian A
J Cardiothorac Vasc Anesth; 2017 Apr; 31(2):626-628. PubMed ID: 27989376
[No Abstract] [Full Text] [Related]
16. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads.
Cheng Y; Gao H; Tang L; Li J; Yao L
Echocardiography; 2016 Nov; 33(11):1689-1696. PubMed ID: 27539645
[TBL] [Abstract][Full Text] [Related]
17. Pacing and Defibrillation Consideration in the Era of Transcatheter Tricuspid Valve Replacement.
Dhindsa DS; Mekary W; El-Chami MF
Curr Cardiol Rep; 2024 May; 26(5):331-338. PubMed ID: 38492178
[TBL] [Abstract][Full Text] [Related]
18. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation.
Fanari Z; Hammami S; Hammami MB; Hammami S; Shuraih M
J Electrocardiol; 2015; 48(5):791-7. PubMed ID: 26216371
[TBL] [Abstract][Full Text] [Related]
19. A hybrid endocardial-epicardial biventricular implantable cardioverter-defibrillator to circumvent the tricuspid valve.
Ip JE; Krishnan U; Girardi LN; Lerman BB
Pacing Clin Electrophysiol; 2021 Feb; 44(2):399-401. PubMed ID: 33085111
[TBL] [Abstract][Full Text] [Related]
20. Tricuspid Valve Dysfunction Caused by Right Ventricular Leads.
Ebrille E; Chang JD; Zimetbaum PJ
Card Electrophysiol Clin; 2018 Sep; 10(3):447-452. PubMed ID: 30172281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
